by TractManager | Oct 26, 2021 | Publications
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Tenex (Tenex Health TX) to administer percutaneous ultrasonic tenotomy to reduce pain and improve quality of life...
by TractManager | Oct 26, 2021 | Health Technology Assessment
Focus of the Report: This report focuses on the efficacy and safety of platelet-rich plasma (PRP) for treatment of venous leg ulcers (VLUs).Technology Description: PRP is an autologous blood preparation with a higher-than-usual concentration of platelets,...
by TractManager | Oct 26, 2021 | Emerging Technology Report
Susvimo (ranibizumab injection) is a refillable ocular implant containing the vascular endothelial growth factor (VEGF) inhibitor ranibizumab indicated for the treatment of patients with neovascular (wet) age-related macular degeneration (AMD) who have previously...
by TractManager | Oct 25, 2021 | Emerging Technology Report
Balstilimab is an investigational intravenous immunotherapy. It inhibits the activity of programmed death-1 (PD-1), an immune checkpoint protein that helps restrain the immune system. Balstilimab is proposed for the second-line treatment of advanced cervical cancer in...
by TractManager | Oct 22, 2021 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Somryst (Pear Therapeutics Inc.) for the treatment of chronic insomnia in adults.If you have a Hayes login, click...
Recent Comments